Stockreport

Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases [Yahoo! Finance]

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF PARIS, January 26, 2026 BUSINESS WIRE )--Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon) [Read more]